Chemical Compound

1H-Benzimidazole-4-carboxylic acid, 3-[[2'-(2-ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-2,3-dihydro-2-oxo-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 3-[[2'-(2-Ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate; Candesartan Cilexetil Imp. D (EP); (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 3-[[2'-(2-Ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate; Candesartan Cilexetil Related Compound D; Candesartan Cilexetil Impurity D

CAS Registry Number 1185256-03-4
返回搜索 申请报价
1H-Benzimidazole-4-carboxylic acid, 3-[[2'-(2-ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-2,3-dihydro-2-oxo-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 3-[[2'-(2-Ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate; Candesartan Cilexetil Imp. D (EP); (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 3-[[2'-(2-Ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate; Candesartan Cilexetil Related Compound D; Candesartan Cilexetil Impurity D 结构式
Primary record

1H-Benzimidazole-4-carboxylic acid, 3-[[2'-(2-ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-2,3-dihydro-2-oxo-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 3-[[2'-(2-Ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate; Candesartan Cilexetil Imp. D (EP); (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 3-[[2'-(2-Ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate; Candesartan Cilexetil Related Compound D; Candesartan Cilexetil Impurity D

库存
686 克
纯度
99.1 %
CAS
1185256-03-4

化合物标识与属性

CAS
1185256-03-4
PubChem CID
71315580
SMILES
CCN1N=C(N=N1)C2=CC=CC=C2C3=CC=C(C=C3)CN4C5=C(C=CC=C5NC4=O)C(=O)OC(C)OC(=O)OC6CCCCC6
Canonical SMILES
CCn1nnc(-c2ccccc2-c2ccc(Cn3c(=O)[nH]c4cccc(C(=O)OC(C)OC(=O)OC5CCCCC5)c43)cc2)n1

名称与同义词

  • 1185256-03-4
  • 2-Desethoxy-2-hydroxy-2H-2-ethyl Candesartan Cilexetil
  • Candesartan Cilexetil EP Impurity D
  • Candesartan Cilexetil Impurity D
  • UNII-01TN699E2L
  • 01TN699E2L
  • Candesartan Cilexetil Impurity D
  • KORFUGQWQJEFIY-UHFFFAOYSA-N
  • C33H34N6O6
  • DTXSID401100403
  • Candesartan cilexetil impurity D [EP]
  • 2-Desethoxy-2-oxo-2H-2-ethyl candesartan cilexetil
  • Candesartan cilexetil Related Compound D
  • MFCD29059997
  • FD21169
  • FT-0665931
  • G87496
  • 2-Desethoxy-2-hydroxy-2H-2-ethylCandesartanCilexetil-d5
  • A986727
  • 1-cyclohexyloxycarbonyloxyethyl 3-[[4-[2-(2-ethyltetrazol-5-yl)phenyl]phenyl]methyl]-2-oxo-1H-benzimidazole-4-carboxylate
  • A1-01750
  • CANDESARTAN CILEXETIL IMPURITY D [EP IMPURITY]
  • Q27231450
  • (1RS)-1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 3-((2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate
  • 1246820-36-9
  • 1H-Benzimidazole-4-carboxylic acid, 3-((2'-(2-ethyl-2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-2,3-dihydro-2-oxo-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester
  • (+/-)1H-Benzimidazole-4-carboxylic acid, 3-((2'-(2-ethyl-2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-2,3-dihydro-2-oxo-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester
  • 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 3-((2'-(2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate
  • 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 3-{[2'-(2-ethyl-2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-2-oxo-2,3-dihydro-1H-1,3-benzodiazole-4-carboxylate
  • (+/-)-1H-BENZIMIDAZOLE-4-CARBOXYLIC ACID, 3-((2'-(2-ETHYL-2H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-2,3-DIHYDRO-2-OXO-, 1-(((CYCLOHEXYLOXY)CARBONYL)OXY)ETHYL ESTER
  • (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 3-[[2'-(2-Ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate
  • (RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl-3-[[2 inverted exclamation mark -(2-ethyl-2H-tetrazol-5-yl)-4-biphenylyl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate
  • 1-(cyclohexoxycarbonyloxy)ethyl 3-[[4-[2-(2-ethyltetrazol-5-yl)phenyl]phenyl]methyl]-2-oxo-1H-benzimidazole-4-carboxylate
  • 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2 inverted exclamation marka-(2-ethyl-2H-tetrazol-5-yl)[1,1 inverted exclamation marka-biphenyl]-4-yl]methyl]-2,3-dihydro-2-oxo-1H-benzimidazole-4-carboxylate
  • 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2a(2)-(2-ethyl-2H-tetrazol-5-yl)[1,1a(2)-biphenyl]-4-yl]methyl]-2,3-dihydro-2-oxo-1H-benzimidazole-4-carboxylate
  • 1-Cyclohexyloxycarbonyloxyethyl 2-oxo-3-[[4-[2-[2-(1,1,2,2,2-pentadeuterioethyl)tetrazol-5-yl]phenyl]phenyl]methyl]-1H-benzimidazole-4-carboxylate
  • 1H-Benzimidazole-4-carboxylic acid, 3-[[2'-(2-ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-2,3-dihydro-2-oxo-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 3-[[2'-(2-Ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate; Candesartan Cilexetil Imp. D (EP); (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 3-[[2'-(2-Ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate; Candesartan Cilexetil Related Compound D; Candesartan Cilexetil Impurity D
  • 2-Hydroxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester
  • 3-[[2'-(2-Ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-2,3-dihydro-2-oxo-1H-benzimidazole-4-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
  • 3-[[2?-(2-Ethyl-2H-tetrazol-5-yl)[1,1?-biphenyl]-4-yl]methyl]-2,3-dihydro-2-oxo-1H-benzimidazole-4-carboxylic acid 1-[[(cyclohexylox y)carbonyl]oxy]ethyl ester